ArticleHuman molecular genetics2020

Systemic AAV9 gene therapy using the synapsin I promoter rescues a mouse model of neuronopathic Gaucher disease but with limited cross-correction potential to astrocytes.

Giulia Massaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.